Go to the profile of ImmuneOncia Therapeutics Inc.

ImmuneOncia Therapeutics Inc.

 

About ImmuneOncia Therapeutics Inc.

ImmuneOncia was established as a joint venture between Sorrento Therapeutics, USA and Yuhan Corporation, Korea, focusing on immuno-oncology and aims to bring safe, effective immunotherapies to patients worldwide.

Therapeutic Areas

Oncology

Technologies

Other

Company Type

Pharmaceutical

State of Ownership

Private

Sponsorship Group

Networker

Topics

Editions participated in:

September 2017 March 2018